Username Password
S&P 500: 1,351.68 Change: +0.14%

PAREXEL INTL CP (PRXL)

Overview
Price 24.29
Price Change Today 0.00 (0.00%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $24.29
Daily Range $0.00 - $0.00
52-Week Range $15.26 - $27.91
Volume 0
chart
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
Other Resources for PRXL
zacks.com
Commentary
Zacks Blog: Company News for May 24, 2011
May 24, 2011
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
 
Brokerage Analyst Recommendations
12 Brokerage Firms Covering PRXL
 
  
Strong Buy
8
Buy
0
Hold
4
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.67
 
PRXL Ratings:BUY  SELL  HOLD
PRXL Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

7 Buy
0 Sell
 
Top Buy Analysis
BUY: PRXL Rating: 3
Company: PAREXEL INTERNATIONAL CORPORATION
Points: -1.16
Start Price: $19.25
Start Date: 02/08/2010 5:43 PM
Aldecoa
Aldecoa
P&P Score: 0.39
Recs:
Speculation. Nothing more.

Comments: 1 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 01/26/10 Zantrio.com Free Daily Stock Picks 1-26-2010 0
Zacks_Analysts
0.00 01/13/11 Merck & Parexel Enter Pact - Analyst Blog 0
Zacks_Analysts
0.00 06/16/10 BMY Candidate Meets Study Goal - Analyst Blog 0
Commentary
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $19.25
Points: -1.16
Created: 02/08/2010
Speculation. Nothing more.

Comments: 1 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $13.02
Points: +43.48
Created: 06/06/2009
Leading global biopharmaceutical services provider.

Comments: 0 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $10.01
Points: +99.15
Created: 01/06/2009

Comments: 0 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $10.01
Points: +98.01
Created: 01/05/2009

Comments: 0 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $26.50
Points: -13.27
Created: 06/26/2008

Comments: 0 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $25.95
Points: +1.95
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: PAREXEL INTERNATIONAL CORPORATION (PRXL) Rating: 3
Start Price: $39.45
Points: -30.23
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Aldecoa 0.39 BUY Three Plus Years 02/08/2010 $19.25 $24.40
(+0.04%)
+26.75% +27.91% -1.16 view
LINDALEIGH BUY One to Three Months 06/06/2009 $13.02 $24.40
(+0.04%)
+87.40% +43.93% +43.48 view
kcook9620 72.92 BUY Week or Less 01/06/2009 $10.01 $24.40
(+0.04%)
+143.76% +44.61% +99.15
krc32 62.84 BUY Week or Less 01/05/2009 $10.01 $24.40
(+0.04%)
+143.76% +45.74% +98.01
LeveneOMurray 0.45 BUY Week or Less 06/26/2008 $26.50 $24.40
(+0.04%)
-7.92% +5.34% -13.27
jszmania 72.43 BUY Six Months to a Year 01/01/2008 $25.95 $24.40
(+0.04%)
-5.97% -7.92% +1.95
Lembesis 33.50 BUY Six Months to a Year 01/01/2008 $39.45 $24.40
(+0.04%)
-38.15% -7.92% -30.23
Sponsored Links